Veterinary Rapid Diagnostic Test Market Regional Analysis

Global Veterinary Rapid Diagnostic Test Market size was valued at USD 934.2 million in 2023 and is poised to grow from USD 1032.29 million in 2024 to USD 2294.57 million by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032). 

Due to the presence of numerous large and minor industry participants, the market is fragmented. To increase their market share, major players are implementing business strategies including diversified product offerings, regional expansion, business expansion, joint ventures, and new product launches. 'IDEXX Laboratories, Inc. (United States) ', 'Zoetis Inc. (United States) ', 'Thermo Fisher Scientific Inc. (United States) ', 'Heska Corporation (United States) ', 'Neogen Corporation (United States) ', 'Virbac (France) ', 'Bio-Rad Laboratories, Inc. (United States) ', 'Biopanda Reagents Ltd (United Kingdom) ', 'BioNote Inc. (South Korea) ', 'Fassisi GmbH (Germany) ', 'MEGACOR Diagnostik GmbH (Austria) ', 'SWISSAVANS AG (Switzerland) ', 'Woodley Equipment Company Ltd. (United Kingdom) ', 'Agrolabo S.p.A. (Italy) ', 'IDvet (France) ', 'iM3Vet Pty Ltd. (Australia) ', 'DiaSys Diagnostic Systems GmbH (Germany) ', 'Ring Biotechnology Co. Ltd (China) ', 'Antech Diagnostics (United States) '

For a sizable portion of the population in developing countries, livestock husbandry is one of the main sources of income and subsistence. Farmers increasingly need to increase livestock production as the demand for food products derived from animals grows on a global scale. However, illnesses like foot and mouth, Newcastle disease, and African swine fever have an impact on the livestock industry's productivity by lowering the quality of food items made from animals.

The rising prevalence of zoonotic illnesses, the advantages of quick tests over other techniques, the demand for at-home/farm testing, and rising public knowledge of veterinary health all contribute to the market's expansion.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). Geographically, the veterinary fast diagnostic tests market is anticipated to be dominated by North America in 2022. North America is predicted to account for the highest proportion thanks to rising veterinary numbers, greater awareness of the value of disease diagnosis in animals, and rising pet health expenditures. The largest CAGR is anticipated to be achieved during the projected period, nevertheless, in Asia-Pacific. Due to the abundance of livestock and the increased prevalence of numerous zoonotic illnesses in the area, the market for veterinary quick diagnostic tests in the Asia-Pacific has experienced significant expansion.